SOUTH SAN FRANCISCO, Calif. — BBOT, a clinical-stage biopharmaceutical company focused on developing therapies for RAS-pathway cancers, has appointed veteran financial executive Uneek Mehra as its new Chief Financial Officer. Mehra brings nearly three decades of global financial leadership experience in the biotechnology and healthcare sectors.
“We are thrilled to welcome Uneek to BBOT,” said Eli Wallace, Ph.D., Chief Executive Officer of BBOT. “His proven track record of driving financial strategy, building high-impact partnerships, and supporting the growth of innovative biotech companies will be instrumental as we continue to advance our promising oncology pipeline and scale our operations.”
Prior to joining BBOT, Mehra served as Chief Financial & Business Officer at 4D Molecular Therapeutics (4DMT), where he led a $325 million financing round and helped allocate capital for two major Phase 3 programs. He previously held the same title at Myovant Sciences Ltd., where he played a key role in forging commercial partnerships, supporting product launches in oncology and women’s health, and overseeing the company’s acquisition by Sumitomo Pharma.
Mehra has also held senior financial roles at PACT Pharma, Proteus Digital Health, and spent 13 years at Novartis, where he was responsible for strategic capital planning and commercial financial performance across several multibillion-dollar divisions. He began his career in finance at IBM and Citibank.
“I am excited to join BBOT at such a pivotal time in its growth,” said Mehra. “The company’s commitment to advancing precision oncology therapeutics—especially its focus on the potential of dual MAPK and PI3Kα inhibition—is deeply inspiring, and I look forward to contributing to its mission of delivering transformative treatments to patients.”
Mehra holds an MBA in Strategy and Leadership from IMD in Lausanne, Switzerland, a Master of Management Studies in Finance from the University of Mumbai, and a Bachelor of Engineering in Electronics from the Birla Institute of Technology and Science (BITS), Pilani.
